Status
Conditions
About
To describe the clinical, electrophysiological, and genetic characteristics of patients with genetic and inflammatory polyneuropathies in France.
Full description
To describe the clinical, electrophysiological, and genetic characteristics of genetic and inflammatory peripheral neuropathies in detail in order to advance our understanding of these rare and disabling diseases. This detailed description is also necessary with a view to the future use of innovative treatments. In recent years, there have indeed been spectacular advances in the field of genetic therapies (siRNA, antisense oligonucleotides, gene therapy) and next-generation immunosuppressive therapies (complement inhibitors, anti-FcRN), all of which are applicable in the short- to medium-term for genetic and inflammatory polyneuropathies.
This is a multicenter, prospective-retrospective study using data collected as part of routine clinical care.The objectives are as follows:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
- Patient opposition to the use of their routine care data for research purposes.
Loading...
Central trial contact
Andoni ECHANIZ-LAGUNA
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal